Literature DB >> 22573687

Differential modulation of the oligodendrocyte transcriptome by sonic hedgehog and bone morphogenetic protein 4 via opposing effects on histone acetylation.

Muzhou Wu1, Marylens Hernandez, Siming Shen, Jennifer K Sabo, Dipti Kelkar, Ju Wang, Robert O'Leary, Greg R Phillips, Holly S Cate, Patrizia Casaccia.   

Abstract

Differentiation of oligodendrocyte progenitor cells (OPCs) into mature oligodendrocytes is regulated by the interplay between extrinsic signals and intrinsic epigenetic determinants. In this study, we analyze the effect that the extracellular ligands sonic hedgehog (Shh) and bone morphogenetic protein 4 (BMP4), have on histone acetylation and gene expression in cultured OPCs. Shh treatment favored the progression toward oligodendrocytes by decreasing histone acetylation and inducing peripheral chromatin condensation. BMP4 treatment, in contrast, inhibited the progression toward oligodendrocytes and favored astrogliogenesis by favoring global histone acetylation and retaining euchromatin. Pharmacological treatment or silencing of histone deacetylase 1 (Hdac1) or histone deacetylase 2 (Hdac2) in OPCs did not affect BMP4-dependent astrogliogenesis, while it prevented Shh-induced oligodendrocyte differentiation and favored the expression of astrocytic genes. Transcriptional profiling of treated OPCs, revealed that BMP4-inhibition of oligodendrocyte differentiation was accompanied by increased levels of Wnt (Tbx3) and Notch-target genes (Jag1, Hes1, Hes5, Hey1, and Hey2), decreased recruitment of Hdac and increased histone acetylation at these loci. Similar upregulation of Notch-target genes and increased histone acetylation were observed in the corpus callosum of mice infused with BMP4 during cuprizone-induced demyelination. We conclude that Shh and Bmp4 differentially regulate histone acetylation and chromatin structure in OPCs and that BMP4 acts as a potent inducer of gene expression, including Notch and Wnt target genes, thereby enhancing the crosstalk among signaling pathways that are known to inhibit myelination and repair.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22573687      PMCID: PMC3412138          DOI: 10.1523/JNEUROSCI.4876-11.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  80 in total

1.  Wnt signaling controls the timing of oligodendrocyte development in the spinal cord.

Authors:  Takeshi Shimizu; Tetsushi Kagawa; Tamaki Wada; Yuko Muroyama; Shinji Takada; Kazuhiro Ikenaka
Journal:  Dev Biol       Date:  2005-06-15       Impact factor: 3.582

2.  Distinct fibroblast growth factor (FGF)/FGF receptor signaling pairs initiate diverse cellular responses in the oligodendrocyte lineage.

Authors:  Dale Fortin; Eran Rom; Haijun Sun; Avner Yayon; Rashmi Bansal
Journal:  J Neurosci       Date:  2005-08-10       Impact factor: 6.167

3.  TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescence.

Authors:  Thijn R Brummelkamp; Roderik M Kortlever; Merel Lingbeek; Flavia Trettel; Marcy E MacDonald; Maarten van Lohuizen; René Bernards
Journal:  J Biol Chem       Date:  2001-12-17       Impact factor: 5.157

4.  Modulation of bone morphogenic protein signalling alters numbers of astrocytes and oligodendroglia in the subventricular zone during cuprizone-induced demyelination.

Authors:  Holly S Cate; Jennifer K Sabo; Daniel Merlo; Dennis Kemper; Tim D Aumann; Julien Robinson; Toby D Merson; Ben Emery; Victoria M Perreau; Trevor J Kilpatrick
Journal:  J Neurochem       Date:  2010-10       Impact factor: 5.372

5.  TGFbeta1 induces Jagged1 expression in astrocytes via ALK5 and Smad3 and regulates the balance between oligodendrocyte progenitor proliferation and differentiation.

Authors:  Yueting Zhang; Jingya Zhang; Kristina Navrazhina; Azeb Tadesse Argaw; Andleeb Zameer; Blake T Gurfein; Celia F Brosnan; Gareth R John
Journal:  Glia       Date:  2010-06       Impact factor: 7.452

6.  Notch receptor activation inhibits oligodendrocyte differentiation.

Authors:  S Wang; A D Sdrulla; G diSibio; G Bush; D Nofziger; C Hicks; G Weinmaster; B A Barres
Journal:  Neuron       Date:  1998-07       Impact factor: 17.173

7.  Epigenetic modifiers are necessary but not sufficient for reprogramming non-myelinating cells into myelin gene-expressing cells.

Authors:  Jia Liu; Juan Sandoval; Sung Tae Doh; Li Cai; Gerardo López-Rodas; Patrizia Casaccia
Journal:  PLoS One       Date:  2010-09-27       Impact factor: 3.240

8.  The level of BMP4 signaling is critical for the regulation of distinct T-box gene expression domains and growth along the dorso-ventral axis of the optic cup.

Authors:  Hourinaz Behesti; James K L Holt; Jane C Sowden
Journal:  BMC Dev Biol       Date:  2006-12-15       Impact factor: 1.978

9.  Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain.

Authors:  Siming Shen; Jiadong Li; Patrizia Casaccia-Bonnefil
Journal:  J Cell Biol       Date:  2005-05-16       Impact factor: 10.539

10.  Regional morphogenesis in the hypothalamus: a BMP-Tbx2 pathway coordinates fate and proliferation through Shh downregulation.

Authors:  Liz Manning; Kyoji Ohyama; Bernhard Saeger; Osamu Hatano; Stuart A Wilson; Malcolm Logan; Marysia Placzek
Journal:  Dev Cell       Date:  2006-12       Impact factor: 12.270

View more
  49 in total

1.  The Wnt Effector TCF7l2 Promotes Oligodendroglial Differentiation by Repressing Autocrine BMP4-Mediated Signaling.

Authors:  Sheng Zhang; Yan Wang; Xiaoqing Zhu; Lanying Song; Xinhua Zhan; Edric Ma; Jennifer McDonough; Hui Fu; Franca Cambi; Judith Grinspan; Fuzheng Guo
Journal:  J Neurosci       Date:  2021-01-15       Impact factor: 6.167

2.  Selective chemical modulation of gene transcription favors oligodendrocyte lineage progression.

Authors:  Mar Gacias; Guillermo Gerona-Navarro; Alexander N Plotnikov; Guangtao Zhang; Lei Zeng; Jasbir Kaur; Gregory Moy; Elena Rusinova; Yoel Rodriguez; Bridget Matikainen; Adam Vincek; Jennifer Joshua; Patrizia Casaccia; Ming-Ming Zhou
Journal:  Chem Biol       Date:  2014-06-19

Review 3.  Epigenetics in NG2 glia cells.

Authors:  Sarah Moyon; Jialiang Liang; Patrizia Casaccia
Journal:  Brain Res       Date:  2015-06-17       Impact factor: 3.252

4.  Chromatin landscape defined by repressive histone methylation during oligodendrocyte differentiation.

Authors:  Jia Liu; Laura Magri; Fan Zhang; Nidaa O Marsh; Stefanie Albrecht; Jimmy L Huynh; Jasbir Kaur; Tanja Kuhlmann; Weijia Zhang; Paul A Slesinger; Patrizia Casaccia
Journal:  J Neurosci       Date:  2015-01-07       Impact factor: 6.167

Review 5.  Cellular and molecular introduction to brain development.

Authors:  Xiangning Jiang; Jeannette Nardelli
Journal:  Neurobiol Dis       Date:  2015-07-13       Impact factor: 5.996

Review 6.  Interplay between transcriptional control and chromatin regulation in the oligodendrocyte lineage.

Authors:  Marylens Hernandez; Patrizia Casaccia
Journal:  Glia       Date:  2015-05-12       Impact factor: 7.452

7.  E2F1 coregulates cell cycle genes and chromatin components during the transition of oligodendrocyte progenitors from proliferation to differentiation.

Authors:  Laura Magri; Victoria A Swiss; Beata Jablonska; Liang Lei; Xiomara Pedre; Martin Walsh; Weijia Zhang; Vittorio Gallo; Peter Canoll; Patrizia Casaccia
Journal:  J Neurosci       Date:  2014-01-22       Impact factor: 6.167

Review 8.  Zebrafish as a model to investigate CNS myelination.

Authors:  Marnie A Preston; Wendy B Macklin
Journal:  Glia       Date:  2014-09-27       Impact factor: 7.452

9.  Maternal separation with early weaning: a rodent model providing novel insights into neglect associated developmental deficits.

Authors:  Becky C Carlyle; Alvaro Duque; Robert R Kitchen; Kelly A Bordner; Daniel Coman; Eliza Doolittle; Xenophonios Papademetris; Fahmeed Hyder; Jane R Taylor; Arthur A Simen
Journal:  Dev Psychopathol       Date:  2012-11

Review 10.  Remyelination therapy for multiple sclerosis.

Authors:  Michael B Keough; V Wee Yong
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.